Expectant Moms,Diabetics, Dialysis Patients Among Highest-Risk For Developing Restless Legs Syndrome —Relaxis, the Only FDA-Cleared Treatment Developed For RLS, Offers Safe, Drug-Free Solution— (NAPSA)—An estimated 12 million Americanssuffer from Restless Legs Syndrome (RLS), a chronic medical condition that causes extreme discomfort and an overwhelming urge to move one’s legs, usually while resting or asleep. Amongthoseat highest risk for developing RLS are people with other serious health conditions, including diabetics and kidney If you or a loved oneis suffering disease patients on dialysis. from RLS, Relaxis is a drug-free Researchers at Harvard Medical option to help. School and the University of Toronto estimate that 25% ofall ity of sleep in people with primary dialysis patients suffer from RLS. RLS. A recently published medical For these patients, having RLS journal article also reported that correlates to poorer quality oflife Relaxis provided RLS patients and increasedrisk of death. with the same sleep improvement Expectant mothers are another as those who had tried medicahigh-risk RLS group. One out of tions, but without the drugs’ every three pregnant women is severesideeffects. To use Relaxis, a person simply projected to develop RLS, with many experiencing increasingly places the low-profile pad under severe symptoms duringtheir sec- their legs when they feel RLS ond andthird trimesters. symptoms starting. They activate While medicationsare typically the pad and choose a vibration prescribed for RLS, pregnant intensity. Relaxis’ vibrations overwomen andthe chronically ill usu- whelm the unpleasant RLS sensaally can’t tolerate these heavy- tions by stimulating the nerves in duty drugs andtheir side effects. the legs with real sensory signals. Fortunately, there is a new, drugRelaxis interrupts the RLS free option: Relaxis. episode and allows the patient to “Relaxis is the only FDA- gently fall asleep. After 30 mincleared medical treatment ever utes of soothing vibratory counterspecifically developed to help stimulation, Relaxis gradually relieve symptomsin patients with ramps down and shuts off without primary RLS,” says Fred Bur- waking the patient, providing bank, M.D., a California-based relief similar to what they would physician. As an RLS sufferer experience by moving theirlegs. himself, Dr. Burbank experienced Relaxis is prescription-only, so the stress and fatigue caused by patients must first talk with their unpredictable RLS attacks that doctor and request a prescription. repeatedly interrupted his sleep. They then contact the company He also wanted to avoid taking and Relaxis is shipped directly to drugs for his condition. This moti- them. “As a former patient, I know vated him to develop Relaxis as a that having RLS is a unique, indiconvenient, non-invasive, drugvidualized experience, which is free treatment. “Many patients want to avoid why we offer Relaxis on a no-risk taking drugs for their RLS. There 30-day trial,” Dr. Burbank says. are serious risks of side effects, “People can try Relaxis and deterdrug interactions, and even the mine how well it works for them potential for dependency and personally.” addiction,” he says. “Moreover, the If you or a loved one is sufferdrugs prescribed for RLS were ing from RLS, please visit originally developed for other con- www.myrelaxis.com to download a ditions such as epilepsy or Parkin- no-cost self-assessment to share with your doctor. Additional inforson’s Disease, not RLS.” For many RLS patients, the mation is available by calling Sendrugs eventually stop working, sory NeuroStimulation Inc., the leaving them no choice but to con- company that makes Relaxis, tolltinuously increase their dosages. free at (888) 475-7435. These drugs also may ultimately “People with RLS don’t have cause patients’ RLS symptoms to to continue suffering. Relaxis is worsen over time. a safe, drug-free, clinically Relaxis: Simple, Proven, proven option. It’s available Effective today and can help people with In clinical studies, Relaxis has RLS sleep better tonight,” Dr. been proven to improve the qual- Burbank concluded.
